BMJ Signals Success
The British Medical Journal carries article from NIHR Signals that celebrates Peter Hajek’s acclaimed efficacy study
-
by Dave Cross
Share on:
NIHR Signals is a route for the latest important health research evidence to reach key decision makers and clinicians within the NHS. It says it, “provides decision makers in the NHS, public health and social care with the latest important research from the NIHR and other health research organisations.”
Signals explains to readers why the study was needed, what the researchers did, what the study found, how this relates to current guidelines and what the implications are of the findings. They are accompanied by commentary from experts in their field, researchers and those working in practice.
In the article published in the BMJ, Rob Cook (Economist Intelligence Unit), Peter Davidson (Wessex Institute) and Rosie Martin (Economist Intelligence Unit) write about a study by Hajek P, Phillips-Waller A, Przulj D, et al.
Why was the study needed?
In 2016, 15.5% of adults smoked yet, although vaping is considered to be much less harmful than smoking, controversy exists over its effectiveness in smoking cessation (efficacy).
They write: “This new study is the first sizeable, long term trial comparing modern refillable e-cigarettes with nicotine replacement therapy (NRT) within the context of existing NHS stop smoking services, where only about 10% of smokers manage to quit with standard care. The trial offers the best evidence yet available about the effectiveness of e-cigarettes combined with behavioural support for smoking cessation.”
What did it find?
- Eighteen per cent of participants randomised to receive e-cigarettes reported themselves to be abstinent from smoking after 12 months, backed up by negative carbon monoxide breath tests. Of these people, 80% were still using e-cigarettes. In total, 39.5% of e-cigarette users were still using them after 12 months
- The chances of having stopped smoking were 83% higher for people who used e-cigarettes compared with NRT
- There were no serious adverse events related to either NRT use or e-cigarette use
The trio concluded: “The finding that e-cigarettes are substantially more effective than NRT products, even when used with expert support, signals a potential shift towards provision of e-cigarettes as part of NHS stop smoking services.”
“This would require training of stop smoking service staff. Potential for purchase of e-cigarettes by services would need to be considered. This publication did not include a cost comparison, but reports that the 2016 cost to the trial of an e-cigarette starter pack was £30.25, compared with £120 for a three-month supply of a single NRT product. This suggests that e-cigarettes might be a good economic choice, as well as more clinically effective, compared with NRT.”
Resources:
- “A Randomized Trial of E-Cigarettes versus Nicotine-Replacement Therapy” by Hajek, Phillips-Waller, Przulj et al – [link]
- “E-cigarettes helped more smokers quit than nicotine replacement therapy” by Cook, Davidson and Martin – [link]
Dave Cross
Journalist at POTVDave is a freelance writer; with articles on music, motorbikes, football, pop-science, vaping and tobacco harm reduction in Sounds, Melody Maker, UBG, AWoL, Bike, When Saturday Comes, Vape News Magazine, and syndicated across the Johnston Press group. He was published in an anthology of “Greatest Football Writing”, but still believes this was a mistake. Dave contributes sketches to comedy shows and used to co-host a radio sketch show. He’s worked with numerous vape companies to develop content for their websites.
Join the discussion
Harm Reduction For The Rich
The United Kingdom risks becoming a harm reduction country only for the wealthy, according to Michael Landl of the World Vapers’ Alliance
-
by Dave Cross
CAPHRA Highlights Tobacco Control Flaws
The Coalition of Asia Pacific Tobacco Harm Reduction Advocates highlights the flaws in tobacco control which has led to the rise of black market in Australia
-
by Dave Cross
A Missed Opportunity at COP10
The Smoke Free Sweden movement says that COP10 was a missed opportunity to save millions of lives
-
by Dave Cross
COP10: Promote Tobacco Harm Reduction
Experts with Smoke Free Sweden are emphasising the urgent need for a Tobacco Harm Reduction approach at COP10
-
by Dave Cross
